Mark Trolice/LinkedIn
Sep 13, 2026, 14:17
Mark Trolice: Could AI-Discovered Drugs Lead to No-Injection IVF?
Mark Trolice, Director of The IVF Center, shared on LinkedIn:
“No Injection IVF?
EMD Serono, has acquired two fertility programs developed by PostEra using AI-assisted drug discovery:
- small-molecule FSH-receptor agonists for ovarian stimulation
- LH/CG-receptor agonists aimed at ovulation triggering and male infertility.
EMD Serono assumes development and potential worldwide commercialization; the programs remain preclinical, so this is a technology bet rather than an imminent clinical replacement for gonadotropins.
Stay tuned!”
Stay informed with the latest updates in fertility and reproductive medicine on Fertility News.
-
Nov 2, 2026, 17:08Elena Milner: The 2nd Class of the School of Embryology Is Already in Full Swing
-
Nov 2, 2026, 17:05November Is National Diabetes Month – PCOS Awareness Association
-
Nov 2, 2026, 17:04Thanos Papathanasiou: Are We Preparing Patients for the IVF Cycle, or for the IVF Journey?
-
Nov 2, 2026, 17:02Anna Morales: Why Is It So Hard to Build in Women’s Health?
-
Nov 2, 2026, 16:59Rickard Ericsson: Honored to Take on the Role of Interim CEO of the Vitrolife Group
-
Nov 2, 2026, 16:56Mohammed Nasur: 1 Small Simulation, A Bigger Purpose
-
Nov 2, 2026, 16:54Carlos Guerrero: Presenting Our Latest Research on AI and Embryo Assessment at ASRM 2026
-
Nov 2, 2026, 16:52Sarah Lewen: My 1st ASRM Is Officially Complete
-
Nov 2, 2026, 16:49Jemma Garratt: Taking on the Role of Kind IVF and Data Science Manager at London Women’s Clinic